322 filings
Page 4 of 17
8-K
udaz3h2icpi
18 Jan 23
NanoVibronix Provides Update on Expanding Access to PainShield
8:30am
8-K
47yzpp2
15 Dec 22
Nanovibronix Announces Results of Annual Meeting of Stockholders Held Today
5:29pm
8-K
y38bdk9
1 Dec 22
NanoVibronix Announces $2.4 Million Registered
6:06am
424B5
ybnz6
30 Nov 22
Prospectus supplement for primary offering
5:29pm
8-K
mo7e2fqg74kqrl0f 8jk
29 Nov 22
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
9:13am
8-K
mq4403yfkoi
16 Nov 22
NanoVibronix Announces Interim Results of Clinical Study for UroShield
8:30am
DEFA14A
a6w2vkv yftn6o7dvtlt
15 Nov 22
Additional proxy soliciting materials
9:26am
DEFA14A
b2nyn8a2u46w5h zs
31 Oct 22
Additional proxy soliciting materials
8:20am
8-K
lben y7jrgnb
19 Oct 22
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
8:30am
8-K
wdjzlv8 gd43fkjm
23 Sep 22
NanoVibronix UroShield Approved for Sale through NHS Internal
8:30am
DEFA14A
vdwzvqgnvr6029uou
15 Sep 22
Additional proxy soliciting materials
9:40am
8-K
26ryzvyw7x
15 Sep 22
Nanovibronix Sets Date for Annual Shareholder Meeting
9:30am
8-K
envq0nw ost
14 Sep 22
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
10:21am
8-A12G
q3tb6are4johh3
14 Sep 22
Registration of securities
9:46am
DEFA14A
7hboyutv3wqj2ndxx2
2 Sep 22
Additional proxy soliciting materials
4:31pm
8-K
wtp586057s5lin
2 Sep 22
Other Events
4:30pm
8-K
j119xls
2 Sep 22
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:30pm